Table 1 Baseline characteristics of individuals with GWAS data available in the Hoorn, DCS study (n = 3466)
From: Genome-wide association study of serum magnesium in type 2 diabetes
Demographics | |
|---|---|
Men (%) | 1973 (57) |
Age (years) | 66 ± 10 |
Duration of diabetes (years) | 5.6 (3.0–10.1) |
Smoking, n (%) | |
Current | 609 (18) |
Former | 1776 (51) |
Never | 1058 (31) |
Missing | 23 (1) |
Metabolic variables | |
BMI (kg/m2) | 29.6 (26.7–33.2) |
SBP (mmHg) | 141 ± 20 |
DBP (mmHg) | 78 ± 9 |
Total cholesterol (mmol/L) | 4.6 ± 1.0 |
Triglycerides (mmol/L) | 1.6 (1.1–2.1) |
HbA1c (%) | 6.5 (6.1–7.1) |
HbA1c (mmol/mol) | 47.5 (43.0–54.0) |
Fasting glucose (mmol/L) | 7.7 (6.9–8.9) |
LDL (mmol/L) | 2.5 ± 0.9 |
HDL (mmol/L) | 1.2 (1.0–1.4) |
Albumin creatine ratio (mg/mmol) | 0.5 (0.0–1.3) |
Serum creatinine (μmol/L) | 78 (67–91) |
eGFR (mL/min/1.73m2) | 79.5 ± 18.3 |
Serum Mg2+ (mmol/L) | 0.80 ± 0.08 |
Medication use, n (%) | |
Insulin | 743 (21) |
Glucose-lowering medication | 2628 (76) |
Diuretics | 1040 (30) |